Yahoo
    HKSE - Delayed Quote HKD

    Brii Biosciences Limited (2137.HK)

    0.980 +0.010 (+1.03%)
    At close: October 30 at 4:08:06 PM GMT+8
    Loading Chart for 2137.HK
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results

    Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results
    PR Newswire 2mo ago
    Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results

    Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results
    PR Newswire 2mo ago
    Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B

    Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B
    PR Newswire 3mo ago
    Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV

    Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV
    PR Newswire 5mo ago
    Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV

    Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV
    PR Newswire 5mo ago
    Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026

    Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026
    PR Newswire 6mo ago
    Brii Biosciences Ltd (STU:7SS) Full Year 2025 Earnings Call Highlights: Strategic Advances Amid ...

    Brii Biosciences Ltd (STU:7SS) Full Year 2025 Earnings Call Highlights: Strategic Advances Amid ...
    GuruFocus.com 7mo ago
    Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B

    Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B
    PR Newswire 3mo ago
    Why Vir Biotechnology (VIR) Is Down 5.1% After Astellas Oncology Deal And Brii Arbitration

    Why Vir Biotechnology (VIR) Is Down 5.1% After Astellas Oncology Deal And Brii Arbitration
    Simply Wall St. 5mo ago
    Brii Biosciences Unveils BRiSC™, an siRNA Therapeutics Discovery Platform

    Brii Biosciences Unveils BRiSC™, an siRNA Therapeutics Discovery Platform
    PR Newswire 16d ago
    Brii Biosciences Unveils BRiSC™, an siRNA Therapeutics Discovery Platform

    Brii Biosciences Unveils BRiSC™, an siRNA Therapeutics Discovery Platform
    PR Newswire 16d ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: